Retatrutide

Description

Short Overview

(CAS N/A) Retatrutide is a novel triple agonist peptide targeting GLP-1, GIP, and glucagon receptors simultaneously. It is actively researched in metabolic disease studies for its potential in weight management and glycemic control through multi-receptor activation. Manufactured with high purity standards, Retatrutide peptide is supplied in lyophilized powder form for convenient handling and long-term stability in research settings.

Product Specifications

Product Name: Retatrutide

Category: Peptide

CAS Number: N/A

Form: Lyophilized Powder

Purity: High-grade research quality

Storage: Store refrigerated (2-8 degrees C) for optimal stability

Available Variants

Key Features

• High-purity Retatrutide peptide
• Lyophilized for improved stability and storage
• Consistent batch quality for research reliability
• Available in 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, and 60 mg vial packaging
• Secure packaging for laboratory use

Research Applications

• Retatrutide is commonly used in studies involving:
• Triple receptor agonism (GLP-1/GIP/Glucagon) studies
• Weight management mechanism research
• Glycemic control pathway analysis
• Metabolic syndrome and obesity studies
• Multi-target peptide pharmacology research

Handling and Storage

• Store in a cool and dry place.
• For long-term storage, keep at 2-8 degrees C or frozen.
• Avoid repeated freeze-thaw cycles.

Important Disclaimer

This product is intended for laboratory research purposes only. It is not intended for human consumption, medical, veterinary, or household use.